Unknown

Dataset Information

0

Ranolazine reduces repolarization heterogeneity in symptomatic patients with diabetes and non-flow-limiting coronary artery stenosis.


ABSTRACT: BACKGROUND:Experimental evidence suggests that ranolazine decreases susceptibility to ischemia-induced arrhythmias independent of effects on coronary artery blood flow. OBJECTIVE:In symptomatic diabetic patients with non-flow-limiting coronary artery stenosis with diffuse atherosclerosis and/or microvascular dysfunction, we explored whether ranolazine reduces T-wave heterogeneity (TWH), an electrocardiographic (ECG) marker of arrhythmogenic repolarization abnormalities shown to predict sudden cardiac death. METHODS:We studied all 16 patients with analyzable ECG recordings during rest and exercise tolerance testing before and after 4 weeks of ranolazine in the double-blind, crossover, placebo-controlled RAND-CFR trial (NCT01754259). TWH was quantified without knowledge of treatment assignment by second central moment analysis, which assesses the interlead splay of T waves in precordial leads about a mean waveform. Myocardial blood flow (MBF) was measured by positron emission tomography. RESULTS:At baseline, prior to randomization, TWH during rest was 54 ± 7 ?V and was not altered following placebo (47 ± 6 ?V, p = .47) but was reduced by 28% (to 39 ± 5 ?V, p = .002) after ranolazine. Ranolazine did not increase MBF at rest. Exercise increased TWH after placebo by 49% (to 70 ± 8 ?V, p = .03). Ranolazine did not reduce TWH during exercise (to 75 ± 16 ?V), and there were no differences among the groups (p = .95, ANOVA). TWH was not correlated with MBF at rest before (r2  = .07, p = .36) or after ranolazine (r2  = .23, p = .06). CONCLUSIONS:In symptomatic diabetic patients with non-flow-limiting coronary artery stenosis with diffuse atherosclerosis and/or microvascular dysfunction, ranolazine reduced TWH at rest but not during exercise. Reduction in repolarization abnormalities appears to be independent of alterations in MBF.

SUBMITTER: Evaristo E 

PROVIDER: S-EPMC6335958 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ranolazine reduces repolarization heterogeneity in symptomatic patients with diabetes and non-flow-limiting coronary artery stenosis.

Evaristo Ederson E   Stocco Fernando G FG   Shah Nishant R NR   Cheezum Michael K MK   Hainer Jon J   Foster Courtney C   Nearing Bruce D BD   Di Carli Marcelo M   Verrier Richard L RL  

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 20170627 1


<h4>Background</h4>Experimental evidence suggests that ranolazine decreases susceptibility to ischemia-induced arrhythmias independent of effects on coronary artery blood flow.<h4>Objective</h4>In symptomatic diabetic patients with non-flow-limiting coronary artery stenosis with diffuse atherosclerosis and/or microvascular dysfunction, we explored whether ranolazine reduces T-wave heterogeneity (TWH), an electrocardiographic (ECG) marker of arrhythmogenic repolarization abnormalities shown to pr  ...[more]

Similar Datasets

| S-EPMC6159406 | biostudies-other
| S-EPMC6448470 | biostudies-literature
2022-12-18 | PXD036800 | Pride
| S-EPMC5606920 | biostudies-literature
| S-EPMC5496976 | biostudies-other
| S-EPMC7315545 | biostudies-literature
| S-EPMC7437396 | biostudies-literature